Strategic MPI Growth Target buyers and research partners leveraging magnetic particle imaging (MPI) for real-time functional imaging, focusing on hospitals and translational research centers already adopting advanced imaging modalities.

Funding & Partners Capitalize on recent seed and Series B funding to approach investors and portfolio companies for co-development, joint ventures, and sponsored studies that expand MPI deployment and validation.

Early Adopter Signals Leverage City of Hope installation as a reference to engage oncology, vascular, and biomarker labs seeking quantitative imaging tools with tissue-depth-insensitive visualization and nanoparticle tracer capabilities.

Product Expansion Identify opportunities to upsell or bundle Momentum CT capabilities withMPI systems, or deliver training, service contracts, and custom imaging protocols to accelerate clinical translation.

Clinical & Market Fit Map MPI to high-value clinical applications such as targeted biomarkers, real-time blood flow analysis, and vascular architecture imaging to align with institutions pursuing precision medicine and functional imaging research.